These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 9815573)

  • 1. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
    Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
    Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus.
    Bonatz G; Frahm SO; Klapper W; Helfenstein A; Heidorn K; Jonat W; Krupp G; Parwaresch R; Rudolph P
    Hum Pathol; 2001 Jun; 32(6):605-14. PubMed ID: 11431715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
    Koeneman KS; Pan CX; Jin JK; Pyle JM; Flanigan RC; Shankey TV; Diaz MO
    J Urol; 1998 Oct; 160(4):1533-9. PubMed ID: 9751408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
    J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
    Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
    Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of telomerase activity and telomere length.
    Wu KD; Moore MA
    Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
    Gümüş-Akay G; Unal AE; Bayar S; Karadayi K; Elhan AH; Sunguroĝlu A; Tükün A
    Genet Mol Res; 2007 Feb; 6(1):41-9. PubMed ID: 17469053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity in cell lines of pediatric soft tissue sarcomas.
    Kleideiter E; Schwab M; Friedrich U; Koscielniak E; Schafer BW; Klotz U
    Pediatr Res; 2003 Nov; 54(5):718-23. PubMed ID: 12904596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].
    Katayama S; Shiota G; Kawasaki H
    Nihon Rinsho; 1998 May; 56(5):1204-8. PubMed ID: 9613123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
    Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
    Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity in giant cell tumors of bone.
    Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Kojima K; Sharman P; Ochi M
    Ann Surg Oncol; 2007 Oct; 14(10):2896-902. PubMed ID: 17653593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
    Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
    Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in primary prostate cancer.
    Lin Y; Uemura H; Fujinami K; Hosaka M; Harada M; Kubota Y
    J Urol; 1997 Mar; 157(3):1161-5. PubMed ID: 9072562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
    Hsu CP; Miaw J; Shai SE; Chen CY
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):425-31. PubMed ID: 15296909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections.
    Tahara H; Yasui W; Tahara E; Fujimoto J; Ito K; Tamai K; Nakayama J; Ishikawa F; Tahara E; Ide T
    Oncogene; 1999 Feb; 18(8):1561-7. PubMed ID: 10102626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity: a prevalent marker of malignant human prostate tissue.
    Sommerfeld HJ; Meeker AK; Piatyszek MA; Bova GS; Shay JW; Coffey DS
    Cancer Res; 1996 Jan; 56(1):218-22. PubMed ID: 8548767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
    Takagi S; Kinouchi Y; Hiwatashi N; Chida M; Nagashima F; Takahashi S; Negoro K; Shimosegawa T; Toyota T
    Cancer; 1999 Oct; 86(8):1431-6. PubMed ID: 10526269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.